Alembic Pharma Appoints Tushar Mehta as Head-R&D (API)

Alembic Pharmaceuticals Ltd has announced the appointment of Mr. Tushar Mehta as Head-R&D (API), a Senior Management Personnel, effective June 3, 2026. Mr. Mehta brings over 24 years of extensive experience in API R&D, having led numerous development programs and commercializations. His expertise spans complex small-molecule APIs, including oncology and antiviral products. Prior to this role, he held senior R&D positions at Cadila Pharmaceuticals and other leading pharmaceutical companies. This appointment is expected to bolster Alembic's research and development capabilities in the API segment.